Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
FDA approves first genetic test to help identify risk of developing opioid use disorder
FDA approves first genetic test to help identify risk of developing opioid use disorder
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
The Brown University Child & Adolescent Psychopharmacology Update
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1002/cpu30840
Similar Items
FDA approves drug to treat neurologic manifestations of Hunter syndrome
Published: (2026)
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
by: Alison Knopf
Published: (2026)
Prescribe for patients with opioid use disorder — with confidence
by: Alison Knopf
Published: (2024)
How to help young adults in the opioid and stimulant crisis
by: Alison Knopf
Published: (2025)
Potential for inflammation biomarkers to identify risk for mental disorders
by: Alison Knopf
Published: (2024)
